Crystal structure of cytochrome P450

Details Crystal structure of cytochrome P450 Crystal structure of cytochrome P450

2006-12-12

2006-12-12

Nashed, Nashaat T. (Department: 1656)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Oxidoreductase

Reexamination Certificate

active

07148046

ABSTRACT:
The invention provides the crystal structure of the cytochrome P450 3A4 protein molecule. The structure is set out in Table 5. The structure may be used in to model the interaction of compounds such as pharmaceuticals with this protein, and to determine the structure of related cytochrome P450 molecules.

REFERENCES:
patent: 5786191 (1998-07-01), Goldstein et al.
patent: 5834250 (1998-11-01), Wells et al.
patent: 5886157 (1999-03-01), Guengerich et al.
patent: 5912120 (1999-06-01), Goldstein et al.
patent: 6080568 (2000-06-01), Day et al.
patent: 6136553 (2000-10-01), Christianson et al.
patent: 6162613 (2000-12-01), Su et al.
patent: 6312917 (2001-11-01), Thakker et al.
patent: 6432639 (2002-08-01), Lichter et al.
patent: 2003/0170842 (2003-09-01), Williams et al.
patent: 195 49 267 (1997-07-01), None
patent: WO 98/02554 (1998-01-01), None
patent: WO 99/08812 (1999-02-01), None
patent: WO 01/11035 (2001-02-01), None
patent: WO 01/14565 (2001-03-01), None
patent: WO 03/035693 (2003-05-01), None
patent: WO 03/040994 (2003-05-01), None
patent: WO 03/102192 (2003-12-01), None
patent: WO 2004/038015 (2004-05-01), None
patent: WO 2004/038655 (2004-05-01), None
Abstract 4, Abstracts from 8thEuropean ISSX Meeting (Monday 28thApr. 2003), Structural Characterisation of Substrate and Inhibitor Binding to 2C P450s, Eric Johnson, Scripps Research Institute, La Jolla, CA, USA.
Wester et al, Structure of a Substrate Complex of Mammalian Cytochrome P450 2CS at 2.3 Å Resolution: Evidence of Multiple Substrate Binding Modes, Biochemistry 2003, 42, 6370-6379.
Wester et al, Structure of Mammalian Cytochrome P450 2C5 Complexed with Diclofenac at 2.1 Å Resolution: Evidence for an Induced Fit Model of Substrate Binding, Biochemistry 2003, 42, 9335-9345.
Crystal Structure of human cytochrome P450 2C9 with bound warfarin; Williams, P.A.; Cosme, J.; Ward, A.; Angrove, H.C.; Matak-Vinkovic, D.; Jhoti, H.;Nature,Jul. 24, 2003; 424(6947); 464-8. (Published online Jul. 13, 2003).
IF Sevrioukova, H Li, H Zhang, JA Peterson, TL Poulos, Structure of a cytochrome P450-redox partner electron-transfer complex,Proceedings of the National Academy of Sciences of the United States of America(1999) 96, pp. 1863-1869.
Szklarz GD, Halpert JR.; Molecular modeling of cytochrome P450 3A4;J. Comput. Aided Mol. Des.;1997;11(3); 265-72.
Lewis DF, Eddershaw PJ, Goldfarb PS, Tarbit MH.; Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals;Xenobiotica;1996; 26(10);1067-86.
Guengerich FP; Cytochrome P-450 3A4: regulation and role in drug metabolism; Annu. Rev. Pharmacol. Toxicol.; 1999; 39;1-17.
Ekins S, Bravi G, Wikel JH, Wrighton SA.; Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates; J Pharmacol Exp Ther.; 1999; 291(1); 424-33.
Ekins S, Bravi G, Binkley S, Gillespie JS, Ring BJ, Wikel JH, Wrighton SA.; Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors; J Pharmacol Exp Ther.; 1999; 290(1); 429-38.
Gonzalez,F.J., Schmid,B.J., Umeno,M., Mcbride,O.W., Hardwick,J.P., Meyer,U.A., Gelboin,H.V. and Idle,J.R., Human P450PCN1: sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase, DNA 7(2), 79-86 (1988).
Beaune,P.H., Umbenhauer,D.R., Bork,R.W., Lloyd,R.S. and Guengerich,F.P., Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase,Proc. Natl. Acad. Sci. U.S.A.;83 (21), 8064-8068 (1986).
Korzekwa, K.R.; Krishnamachary, N.; Shou, M.; Ogai, A.; Parise, R.A.; Rettie, A.E.; Gonzalez, F.J.; Tracey, T.S.; Evaluation Of Atypical Cytochrome P450 Kinetics With Two-Substrate Models: Evidence That Multiple Substrate Can Bind Simultaneously Bind To Cytochrome P450 Active Sites;Biochemistry;1998, vol. 37, 4137-4147.
Hosea NA, Miller GP, Guengerich FP.; Elucidation of distinct ligand binding sites for cytochrome P450 3A4;Biochemistry;2000; 39(20), 5929-39.
Williams, P.; Cosme, J.; Sridhar, V.; Johnson, E. and McRee, D.; Microsomal cytochrome P450 2C5: comparison of microbial P450s and unique features,Journal of Inorganic Biochemistry,2000, vol. 81, pp. 183-190.
T. H. Richardson, F. Jung, K. J. Griffin, M. Wester, J. L. Raucy, B. Kemper, L. M. Bornheim, C. Hassett, C. J. Omiecinski and E. F. Johnson; A Universal Approach to the Expression of Human and Rabbit Cytochrome P450s of the 2C Subfamily inEscherichia coli; Archives of Biochemistry and Biophysics,1995, vol. 323, 87-96.
JP10033166A2; Mass Expression System Of Modified Substance Of Ctochrome P450 2c19 inEscherichia Coli;Inventor: Baba Takahiko; Kirita Shiro; Aoyama Junko; Assignee: Shionogi & Co Ltd; Filed: Jul. 23, 1996. (with English abstract.).
Barnes HJ, Arlotto MP, Waterman MR; Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase inEscherichia coli; Proc. Natl. acad. Sci. USA;1991, 88, 5597-5601.
Kempf AC, Zanger UM, Meyer UA; Truncated human P450 2D6: expression inEscherichia coli,Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation;Arch. Biochem. Biophys.,1995, 321, 277-288.
Gillam EM, Guo Z, Martin MV, Jenkins CM, Guengerich FP; Expression of cytochrome P450 2D6 inEscherichia coli,purification, and spectral and catalytic characterization;Arch. Biochem. Biophys.,1995, 319, 540-550.
Pernecky SJ, Larson JR, Philpot RM, Coon MJ; Expression of truncated forms of liver microsomal P450 cytochromes 2B4 and 2E1 inEscherichia coli;influence of NH2-terminal region on localization in cytosol and membranes;Proc. Natl. Acad. Sci. USA,1993, 90, 2651-2655.
JR Larson, MJ Coon, and TD Porter; Alcohol-inducible cytochrome P-450IIE1 lacking the hydrophobic NH2-terminal segment retains catalytic activity and is membrane-bound when expressed inEscherichia coli; J. Biol. Chem,1991, 266, 7321-7324.
Sagara Y., Barnes H. J. and Waterman M. R.; Expression inEscherichia coliof Functional Cytochrome P450c17Lacking Its Hydrophobic Amino-Terminal Signal Anchor,Arch. Biochem. Biophys.,1993, 304, 272-278.
Emily E. Scott, Margit Spatzenegger and James R. Halpert ; A Truncation of 2B Subfamily Cytochromes P450 Yields Increased Expression Levels, Increased Solubility, and Decreased Aggregation While Retaining Function,Arch. Biochem. Biophys.,2001, vol. 395, Issue 1, 57-68.
Gillam EM, Baba T, Kim BR, Ohmori S, Guengerich FP; Expression of modified human cytochrome P450 3A4 inEscherichia coli;and purification and reconstitution of the enzyme;Arch Biochem Biophys.,1993; 305(1): 123-31.
Meehan,R.R., Gosden,J.R., Rout,D., Hastie,N.D., Friedberg,T., Adesnik,M., Buckland,R., van Heyninen,V., Fletcher,J.M., Spurr,N.K., Sweeney,J. and Wolf,C.R.; Human cytochrome P-450 PB1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10;Am. J. Hum. Genet.;1988, 42 (1), 26-37.
Kimura,S., Pastewka,J., Gelboin,H.V. and Gonzalez,F.J.; cDNA and amino acid sequences of two members of the human P450IIC gene subfamily;Nucleic Acids Res.;1987, 15 (23), 10053-10054.
Romkes,M., Faletto,M.B., Blaisdell,J.A., Raucy,J.L. and Goldstein,J.A.; Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily;Biochemistry;1991, 30 (13), 3247-3255.
Gonzalez,F.J., Vilbois,F., Hardwick,J.P., McBride,O.W., Nebert,D.W., Gelboin,H.V. and Meyer,U.A.; Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22;Genomics,1988, vol. 2 (2), 174-179.
David R. Nelson et al., P450 Superfamily: update on new sequences, gene mapping, accession numbers and nomenclature,Pharmacogenetics6 1-42 (1996).
Nienaber et al., Re-engineering of Human Urokinase Provides a System for Structure-based Drug Design at High Resolution and Reveals a Novel Structural Subsite,J. Biol. Chem.275(10) 7239-7248 (2000).
Dale et al., Crystal Engineering: deletion mutagenesis of the 24 kDa fragment of the DNA gyrase B subunit fro

Affiliated with

Also associated with

Rating

Crystal structure of cytochrome P450 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystal structure of cytochrome P450, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal structure of cytochrome P450 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3672408